AQST Stock Summary and Trading Ideas (Aquestive Therapeutics | NASDAQ:AQST)

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

What symbol and exchange does Aquestive Therapeutics shares trade?

Aquestive Therapeutics trades on the NASDAQ stock market under the symbol AQST.

What is Aquestive Therapeutics stock price doing today?

As of August 21, 2026, AQST stock price climbed to $4.66 with 1,929,100 million shares trading.

What is Aquestive Therapeutics's Beta?

AQST has a beta of 0.21, meaning it tends to be less sensitive to market movements. AQST has a correlation of 0.00 to the broad based SPY ETF.

How much is Aquestive Therapeutics worth?

AQST has a market cap of $584.60 million. This is considered a Small Cap stock.

How much money does Aquestive Therapeutics make?

Last quarter Aquestive Therapeutics reported $14 million in Revenue and -$.18 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.06.

What is the highest and lowest price Aquestive Therapeutics traded in the last 3 year period?

In the last 3 years, AQST traded as high as $7.55 and as low as $1.25.

What are the top ETFs holding Aquestive Therapeutics?

The top ETF exchange traded funds that AQST belongs to (by Net Assets): IWM, VTI, XPH, VXF, IWN.

Is Aquestive Therapeutics (AQST) a good investment?

AQST has underperformed the market in the last year with a return of +19.2%, while SPY returned +21.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AQST shares. However, AQST has outperformed the market in the last 3 month and 2 week periods, returning +10.2% and +18.3%, while SPY returned +3.4% and -1.0%, respectively. This indicates AQST has been having a stronger performance recently.

What are the support and resistance levels for Aquestive Therapeutics (AQST)?

AQST support price is $4.31 and resistance is $4.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AQST shares will trade within this expected range on the day.